Medical Properties Trust Inc. logo

Medical Properties Trust Inc.

MPT | NYSE
Chart Builder DCF Calculator
$2.25
-$0.19 (-7.60%)
At close: Oct 30, 2026, 4:00 PM ET
$2.27
+$0.02 (+0.89%)
Pre-market: Nov 2, 2026, 5:03 AM ET

Market Data

Market Cap
$1.34B
Enterprise Value
$10B
Beta
1.49
Average Volume
10.18M
Shares Outstanding (Diluted)
597.16M
Shares Change YoY
-0.62%
Institutional Ownership
N/A
Exchange
NYSE
ISIN
US58463J3041

Price Performance

Price Change 1M
-35.0%
Price Change 3M
-51.4%
Price Change 6M
-55.5%
Price Change YTD
-55.0%
Price Change 1Y
-56.5%
Price Change 3Y
-52.9%
Price Change 5Y
-89.5%
1M CAGR (ann.)
-33.8%
1Y CAGR (ann.)
-50.0%
5Y CAGR (ann.)
-30.0%
All-Time CAGR
-1.4%

Valuation

PE Ratio
5.36
Forward PE
35.38
PEG Ratio
0.00
Forward PEG
-0.05
PS Ratio
1.30
Forward PS
1.30
PB Ratio
0.29
P/FCF Ratio
5.92
P/Adj. FCF Ratio
5.99
P/OCF Ratio
5.92
EV/Sales
9.70
EV/EBIT
9.36
EV/EBITDA
7.40
EV/FCF
44.11
Earnings Yield
18.7%
FCF Yield
16.9%
Adj. FCF Yield
16.7%

Financial Health

Net Debt
$8.66B
Total Debt
$9.26B
Cash & Short-Term Investments
$599.28M
Total Assets
$14.39B
Current Ratio
1.49
Quick Ratio
1.49
Debt / Equity Ratio
2.00
Debt / EBITDA
6.85
Debt / FCF
40.83
OCF / Debt
0.02
Interest Coverage
1.03
Altman Z-Score
0.02
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
82.5%
Operating Profit Margin
55.1%
EBITDA Margin
131.0%
Net Profit Margin
24.1%
FCF Margin
22.0%
Adj. FCF Margin
21.8%
SBC / Revenue
0.2%
SBC Impact (per share)
-1.1%

Returns

Return on Assets
1.7%
Return on Equity
5.5%
Return on Invested Capital
4.1%
Return on Capital Employed
4.1%
Return on Tangible Assets
1.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
-9.8%
Revenue CAGR 5Y
-7.2%
Revenue CAGR 10Y
7.1%
EPS CAGR 3Y
140.2%
EPS CAGR 5Y
-15.2%
EPS CAGR 10Y
-8.1%
FCF CAGR 3Y
-28.0%
FCF CAGR 5Y
-18.1%
FCF CAGR 10Y
-4.6%

Analyst Forecasts

Analyst Rating
Sell
Analyst Count
2
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
2.7%
Earnings Date
Feb 18, 2027
EPS Estimate (next Q)
$0.00
EPS Growth Est (next Q)
-93.5%
Revenue Est (next Q)
$246.3M
Revenue Growth Est (next Q)
-8.9%

Fair Value Estimates

Graham Number
$8.55
Graham Upside
280.0%
Lynch Fair Value
$2.10
Lynch Upside
-6.7%
Price Target
$2.90
Price Target Upside
28.9%

Cash Flow

Operating Cash Flow
$226.82M
Free Cash Flow
$226.82M
Adj. Free Cash Flow
$224.42M
FCF Per Share
$0.38
OCF Per Share
$0.38
OCF/S Ratio
22.0%

Income Statement

Revenue
$1.03B
Gross Profit
$850.86M
Operating Income
$568.66M
EBITDA
$1.35B
Net Income
$249.13M
EPS (Diluted)
$0.42
Revenue / Employee
$8.53M
Profit / Employee
$2.06M
Employees
121

Dividends

Annual Dividend
$0.36
Dividend Yield
16.00%
Payout Ratio
85.7%
FCF Payout Ratio
91.0%
Adj. FCF Payout Ratio
91.9%
Dividend Growth (YoY)
50.0%
Pay Frequency
Quarterly
Ex-Dividend Date
Sep 10, 2026

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.